drugset / Trial / NCT07569302

Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger

NCT07569302

Phase 2 Not yet recruiting 196 enrolled Bedaya Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol \[a single bolos of HCG combined with two successive doses of a GnRH agonist \] with HCG \[a single bolos administered 36 hours before oocyte retrieval \] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.

Timeline

Start
2026-06-01
Primary completion
2027-12-01
Completion
2028-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator HCG Unknown 10000 iu Intramuscular
Subject Triptorelin Other / unclassified 0.1 mg Subcutaneous

Indications